These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 13282525)

  • 1. Suppression of gastric hydrochloric acid secretion by enzyme inhibitors; a new approach in research on the therapy of peptic ulcer.
    HOLLANDER F; JANOWITZ HD
    AMA Arch Intern Med; 1956 Feb; 97(2):194-200. PubMed ID: 13282525
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of carbonic anhydrase inhibitors and antacids on the development of gastrointestinal ulcers during treatment with depot-histamine; a preliminary report.
    HARRISSON JW; PACKMAN EW; GUTH PS; BACK N; CHERNICK WS
    J Am Pharm Assoc Am Pharm Assoc; 1955 Feb; 44(2):123-5. PubMed ID: 14353732
    [No Abstract]   [Full Text] [Related]  

  • 3. [Testing of acid-binding and secretion-inhibiting substances with the aid of intragastric pH-measurement].
    KINZLMEIER H; HENNING N; DEMLING L
    Klin Wochenschr; 1954 Jan; 32(1-2):40-5. PubMed ID: 13143680
    [No Abstract]   [Full Text] [Related]  

  • 4. Pepsins, peptic activity, and peptic inhibitors.
    Samloff IM
    J Clin Gastroenterol; 1981; 3(Suppl 2):91-4. PubMed ID: 6119339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nocturnal pH variations in the antrum after administration of the most commonly used antacids].
    LYNGGAARD HANSEN H
    Nord Med; 1951 Aug; 46(35):1297-1300. PubMed ID: 14882611
    [No Abstract]   [Full Text] [Related]  

  • 6. The antacid effect of dihydroxyaluminum sodium carbonate (DASC) as determined in the gastric-fistula-dog.
    HARRISSON JW; PACKMAN EW
    J Am Pharm Assoc Am Pharm Assoc; 1956 Jan; 45(1):21-3. PubMed ID: 13278255
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of a carbonic anhydrase inhibitor, acetazoleamide, upon gastric secretion in man; report of its use separately and in conjunction with anticholinergic drugs.
    TEXTER EC; BARBORKA CJ
    Gastroenterology; 1955 Apr; 28(4):519-30; discussion, 531-5. PubMed ID: 14366117
    [No Abstract]   [Full Text] [Related]  

  • 8. Problems associated with assessment of the effects of diet, antacids, and amicholinergic agents on gastric and duodenal acidity, as measured by the glass electrode in situ.
    ROVELSTAD RA; MAHER FT
    Gastroenterology; 1962 May; 42():588-94. PubMed ID: 14494602
    [No Abstract]   [Full Text] [Related]  

  • 9. The limitations of current therapy in peptic ulcer disease.
    Salena BJ; Hunt RH
    Clin Invest Med; 1987 May; 10(3):171-7. PubMed ID: 3304747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Problems associated with assessment of the effects of diet, antacids, and anticholinergic agents on gastric and duodenal acidity, as measured by the glass electrode in situ.
    ROVELSTAD RA; MAHER FT
    Gastroenterology; 1962 May; 42():588-94. PubMed ID: 14494603
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro neutralizing capacity of commercially available antacid mixtures, and their role in the treatment of peptic ulcer.
    Clain JE; Wright JP; Price RN; Marks IN
    S Afr Med J; 1980 Feb; 57(5):158-60. PubMed ID: 7404127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A critical look at the clinical use of antacids in acid-peptic disease and gastric acid rebound.
    Texter EC
    Am J Gastroenterol; 1989 Feb; 84(2):97-108. PubMed ID: 2644821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of gastric secretion of hydrochloric acid in vivo by carbonic anhydrase inhibition.
    JANOWITZ HD; COLCHER H; HOLLANDER F
    Nature; 1952 Sep; 170(4325):499. PubMed ID: 12993214
    [No Abstract]   [Full Text] [Related]  

  • 14. Suppression of acid secretion in peptic ulcer disease.
    Feldman M
    J Clin Gastroenterol; 1995; 20 Suppl 1():S1-6. PubMed ID: 7673607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [CLINICAL SIGNIFICANCE OF THE DETERMINATION OF UROPEPSINOGEN IN PEPTIC ULCER].
    LUZHIS AR; RYSS IeS
    Vestn Akad Med Nauk SSSR; 1963; 18():60-5. PubMed ID: 14133795
    [No Abstract]   [Full Text] [Related]  

  • 16. Historical impact to drive research in peptic ulcer disease.
    Banić M; Malfertheiner P; Babić Z; Ostojić R; Kujundzic M; Fatović-Ferenčić S; Plesko S; Petričušić L
    Dig Dis; 2011; 29(5):444-53. PubMed ID: 22095008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antacids and antipeptic agents].
    Belousov AS; Mamedova LD; Zel'din VE; Rakitskaia LG; Loranskaia ID
    Klin Med (Mosk); 1989 Sep; 67(9):123-9. PubMed ID: 2511377
    [No Abstract]   [Full Text] [Related]  

  • 18. Antacids in the treatment of peptic ulcer disease.
    Garrigues-Gil V
    Methods Find Exp Clin Pharmacol; 1989; 11 Suppl 1():73-7. PubMed ID: 2657291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Newer drugs in ocular therapy.
    COSTNER AN
    South Med J; 1955 Nov; 48(11):1192-4. PubMed ID: 13267594
    [No Abstract]   [Full Text] [Related]  

  • 20. [Relations of acid-base balance and gastric secretion of hydrogen carbonate ions in patients with peptic ulcer].
    Malov IuS; Kulikov AN; Ivashkina TG
    Ter Arkh; 2001; 73(2):6-10. PubMed ID: 11338859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.